GREY:IMVIF - Post by User
Post by
QM4455on Feb 23, 2021 10:52am
205 Views
Post# 32636475
Another Ball dropped
Another Ball droppedI'll make this brief.
(I can't post under my old account, stockhouse got some issues)
Once again count on Ors and Labbe to do..... NOTHING.
The stock had a nice run up past $4US, breaking the lower lows pattern in effect for the last few years and there was a nice bid to IMV for a brief moment. Instead of capitalizing on that our dear mngmt dropped the ball again by delivering nothing as they have for the better part of last year.
I am going to stick around for one more month and see if they can deliver on ANY of the many milestones promissed for this quarter, but I am not holding my breath.
Overall, this management team went from competent if not stellar few years back to inept today.
When poorly managed biotechs such us ONC outperform IMV that tells you something.
Such a shame these guys can't get their act together given the strength of the platform.
As for VR leaving I don't blame them. They got in on vaccine play back in March, rode the train. IMV delivered ZERO on Covid side so they bailed.
They were never here for oncology, still, loosing institutional support is never helpful.
Another strike against Ors and Co for not able to keep them around.